Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Ultromics, the UK-based developer of a system that uses artificial intelligence to analyse echocardiograms, completed a $10m financing round on Tuesday featuring medical research and care provider Mayo Clinic, Oxford Sciences Innovation (OSI) and Nina Capital. OSI supplied an undisclosed amount of seed capital for Ultromics in 2017 before returning for a $13.4m series A round in May 2018 alongside Neptune, RT Ventures, GT Healthcare, Tanarra, Fushia and angel investors Andre Crawford-Brunt and Dieter Spält.
Kasada, the US-based creator of…
